Member Info for jackdaw99

The. main difference is that they wouldn't be targeting skin infections!

"13.09 buy 1.9 m looking good for some one gla"

... and the rest !

In my experience, experts generally don't call themselves experts.

".....but I think Lamellar have got round that problem". By not being intravenous and delivering a lower systemic dose???Perhaps, and it would be nice, but I'd like to see some evidence!

... and there it is. Perhaps more to come later?

... says something.

Except most posters put it like this "I feel the breaks have come of. "

Different brokers offering different prices?

DJ, Those ask prices of 1.40 and 1.80 you are seeing are unrealistic - just window dressing. Everything else points to buys IMO.

... surely significant?

66,666 !!

Surely significant. Belzeebub buying?

.... Wednesday was supposed to be a good day? Can't get good clairvoyants these days.

https://www.theguardian.com/world/2020/jun/01/who-warns-overuse-of-antibiotics-for-covid-19-will-cause-more-deaths

Well, if anyone genuinely knew something, they still couldn't tell you! No point asking.

Triflepig, Even IF liver toxicity is a substantive issue after further investigation (which IS needed to confirm or otherwise), lots of theraputics cause liver problems yet the risk/reward ratio keeps them on the market. AND, yes, all sorts of technology/biology changes could make Iclaprim valuable.

Mark, I understand. It's just that I wouldn't want people to be persuaded by the claims, not yours, that the future is necessarily the same as the past.

Not yet. Though they probably will one day, by phage I would imagine.

It's for 37000 shares. Peanuts.

B1ll, I'd reply but I genuinely don't know what you mean.

While I appreciate the time and effort that goes into the history lesson (by both posters) that is Iclaprim, I do feel the need to point out that the past is pretty irrelevant, especially in the world of biotech, where altered circumstances can turn things on a sixpence. Those looking to the past are like nineteenth century investors buying animal-fat candles, not believing that mineral oils are about to shake the world of heat and light. Or people in 2019 investing in retail properties. It's all about the future - that's what makes it a bit of a gamble.